Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
The government-wide effort aims to develop the next generation of COVID-19 treatments to prepare the U.S. to respond to future virus threats
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
One link between coronaviruses (COVID-19) and the HIV drug Kaletra dates back to the 2003 outbreak of SARS.
An update after switching HIV medication from 5 pills daily, to a single tablet.
The National Institute of Allergy & Infectious Diseases (NIAID) has awarded a $3.2 million grant to further study the antiviral effects of...
Researchers at the Massachusetts Institute of Technology’s Lincoln Laboratory have developed and demonstrated a novel broad-spectrum antiviral...
Researchers found a new antiviral drug that appears to effectively target not only HIV, but also Ebola, influenza and Rift Valley fever, accor...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.